Cisatracurium Besylate

苯磺顺阿曲库铵

Report date: 2024/03/18 09:48:05
NME

Base Information

Drug NameCisatracurium Besylate
Drug Alias Namebesilato de cisatracurio顺苯磺酸阿曲库铵顺苯磺阿曲库铵Cisatracurium besilate苯磺顺阿曲库胺 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonistsMuscle relaxation agents
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsMuscle HypotoniaRespiratory Distress Syndrome, AdultAnesthesia
Global Approved IndicationsMuscle HypotoniaAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved Date1995/12/15
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesWellcome Foundation Ltd
Inactive CompaniesAbbvie IncNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsAnesthesia
Inactive IndicationsMuscle HypotoniaRespiratory Distress Syndrome, Adult

Other Information

ATC CodeM03AC11
Related LinksWikipediaDrugBankKEGG